Funder
the National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference37 articles.
1. Smith D, Stewart C, Clarke EM, Lose F, et al. ER and PR expression and survival after endometrial cancer. Gynecol Oncol. 2018;148(2):258–66.
2. Cuevas IC, Sahoo SS, Kumar A, Zhang H, et al. Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition. Proc Natl Acad Sci USA. 2019;116(51):25880–90.
3. Guo JL, Tang T, Li JH, Yang YH, Zhang L, Quan Y. LncRNA HEIH enhances paclitaxel-tolerance of endometrial cancer cells via activation of MAPK signaling pathway. Pathol Oncol Res. 2019;8:1–10.
4. Waheed S, Cheng RY, Casablanca Y, Maxwell GL, Wink DA, Syed V. Nitric oxide donor DETA/NO inhibits the growth of endometrial cancer cells by upregulating the expression of RASSF1 and CDKN1A. Molecules. 2019;24(20):3722.
5. Vale CL, Tierney J, Bull SJ, Symonds PR. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. Cochrane Database Syst Rev. 2012. https://doi.org/10.1002/14651858.CD003915.pub4.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献